title: Cabazitaxel rechallenge at prostate-specific antigen relapse after previous cabazitaxel and docetaxel chemotherapy: case report.
authors.affiliation: Department of Clinical Oncology, Nottingham City Campus, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom. cperry@doctors.org.uk
authors.forename: Christina J
authors.initials: CJ
authors.lastname: Perry
authors.forename: Santhanam
authors.initials: S
authors.lastname: Sundar
mesh_terms: D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000556:secondary; D000077143:Docetaxel; D019008:Drug Resistance, Neoplasm; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local; D011239:Prednisolone / Q000008:administration & dosage; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D043823:Taxoids / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D043823:Taxoids; D000077143:Docetaxel; C552428:cabazitaxel; D011239:Prednisolone; D017430:Prostate-Specific Antigen